Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1981 Nov;46(5):498–502. doi: 10.1136/hrt.46.5.498

Comparative study of atenolol, metoprolol, metoprolol durules, and slow-release oxprenolol in essential hypertension.

R G Wilcox, J R Hampton
PMCID: PMC482685  PMID: 6119103

Abstract

Twenty-five patients with moderate essential hypertension (standing diastolic blood pressure 100-125 mmHg, phase 5) completed a single-blind placebo-controlled cross-over study comparing four week periods of treatment with atenolol 100 mg, metoprolol 100 mg, metoprolol durules 200 mg, slow-release oxprenolol 160 mg, and slow-release oxprenolol 320 mg respectively. All the drugs were significantly better than placebo at reducing resting blood pressure at 24 hours. Atenolol produced the greatest mean reduction of pressure and was the most effective drug for most patients, though the differences between atenolol and metoprolol durules were not statistically significant. These two drugs, however, were significantly more effective than the remainder. A similar ranking was seen with respect to the reduction of the blood pressure and heart rate response to exercise. None of the treatments had any significant effect on the patients' rating of perceived exertion during the exercise test.

Full text

PDF
498

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams-Strump B. J., Hayes J., Barber J. H. A new approach to drug trials in general practice. Comparison of the antihypertensive efficacy of metoprolol and atenolol. Practitioner. 1980 May;224(1343):541–544. [PubMed] [Google Scholar]
  2. Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med. 1970;2(2):92–98. [PubMed] [Google Scholar]
  3. Brown H. C., Carruthers S. G., Johnston G. D., Kelly J. G., McAinsh J., McDevitt D. G., Shanks R. G. Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker. Clin Pharmacol Ther. 1976 Nov;20(5):524–534. doi: 10.1002/cpt1976205524. [DOI] [PubMed] [Google Scholar]
  4. Bulpitt C. J. Why treat hypertension? Proc R Soc Med. 1977;70(Suppl 5):28–30. doi: 10.1177/00359157770700S513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Comerford M. B., Besterman E. Dosing intervals in beta-blocker therapy. Lancet. 1980 Nov 29;2(8205):1196–1196. doi: 10.1016/s0140-6736(80)92629-x. [DOI] [PubMed] [Google Scholar]
  6. Erikssen J., Mundal R., Thaulow E., Nitter-Hauge S. Dosing intervals in beta blocker therapy. Lancet. 1981 Jan 3;1(8210):51–52. doi: 10.1016/s0140-6736(81)90166-5. [DOI] [PubMed] [Google Scholar]
  7. Kendall M. J., John V. A., Quarterman C. P., Welling P. G. A single and multiple dose pharmacokinetic and pharmacodynamic comparison of conventional and slow-release metroprolol. Eur J Clin Pharmacol. 1980 Feb;17(2):87–92. doi: 10.1007/BF00562615. [DOI] [PubMed] [Google Scholar]
  8. Leahey W. J., Neill J. D., Varma M. P., Shanks R. G. Comparison of the activity and plasma levels of oxprenolol, slow release oxprenolol, long acting propranolol and sotalol. Eur J Clin Pharmacol. 1980 Jun;17(6):419–424. doi: 10.1007/BF00570158. [DOI] [PubMed] [Google Scholar]
  9. Lyngstam O., Rydén L. Metoprolol or atenolol for mild-to-moderate hypertension. Lancet. 1979 Sep 22;2(8143):634–634. doi: 10.1016/s0140-6736(79)91690-8. [DOI] [PubMed] [Google Scholar]
  10. Myers M. G., Thiessen J. J. Metoprolol kinetics and dose response in hypertensive patients. Clin Pharmacol Ther. 1980 Jun;27(6):756–762. doi: 10.1038/clpt.1980.106. [DOI] [PubMed] [Google Scholar]
  11. Pearson S. B., Banks D. C., Patrick J. M. The effect of beta-adrenoceptor blockade on factors affecting exercise tolerance in normal man. Br J Clin Pharmacol. 1979 Aug;8(2):143–148. doi: 10.1111/j.1365-2125.1979.tb05812.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Petrie J. C., Jeffers T. A., Robb O. J., Scott A. K., Webster J. Atenolol, sustained-release oxprenolol, and long-acting propranolol in hypertension. Br Med J. 1980 Jun 28;280(6231):1573–1574. doi: 10.1136/bmj.280.6231.1573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. West M. J., Kendall M. J., Mitchard M., Faragher E. B. A comparison of slow release with conventional oxprenolol: plasma concentrations and clinical effects. Br J Clin Pharmacol. 1976 Jun;3(3):439–443. doi: 10.1111/j.1365-2125.1976.tb00619.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Wilson M., Morgan G., Morgan T. The effect on blood pressure of beta-adrenoceptor blocking drugs administered once daily and their duration of action when therapy is ceased. Br J Clin Pharmacol. 1976 Oct;3(5):857–861. doi: 10.1111/j.1365-2125.1976.tb00638.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES